Tyra Biosciences, Inc. TYRA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $111.43M+8.3% | $102.93M+6.2% | $96.92M+2.9% | $94.15M+7.2% | $87.84M+9.7% | ||
| $31.48M+5.5% | $29.83M+2.6% | $29.07M+5.7% | $27.5M+6.2% | $25.89M+7.3% | ||
| $142.91M+7.6% | $132.76M+5.4% | $125.99M+3.6% | $121.65M+7.0% | $113.73M+9.1% | ||
| -$142.91M-7.6% | -$132.76M-5.4% | -$125.99M-3.6% | -$121.65M-7.0% | -$113.73M-9.1% | ||
| $11.81M-7.9% | $12.82M-10.4% | $14.31M-9.6% | $15.82M-8.5% | $17.29M-2.4% | ||
| -$131.11M-9.3% | -$119.95M-7.4% | -$111.68M-5.5% | -$105.83M-9.7% | -$96.44M-11.5% | ||
| -$2.17-8.5% | -$2.00-7.0% | -$1.87-5.1% | -$1.78-9.2% | -$1.63-7.9% | ||
| -$142.37M-7.7% | -$132.22M-5.4% | -$125.43M-3.6% | -$121.1M-7.0% | -$113.19M-9.2% | ||
| -$142.91M-7.6% | -$132.76M-5.4% | -$125.99M-3.6% | -$121.65M-7.0% | -$113.73M-9.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Tyra Biosciences, Inc. profitable?
- Tyra Biosciences, Inc. is not currently profitable: it reported a net loss of $131.1M over the trailing twelve months.
- What is Tyra Biosciences, Inc.'s earnings per share?
- Tyra Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-2.17.
- Where does Tyra Biosciences, Inc.'s income statement data come from?
- Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.